ArticleScientific reports2026

2'-Nitroflavone targets PARP1 and alters cytoskeleton to inhibit triple-negative breast cancer progression.

Vanina S Vachetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.